Induction of the Immunoproteasome Subunit Lmp7 Links Proteostasis and Immunity in α-Synuclein Aggregation Disorders

EBioMedicine
Scott UgrasHarry Ischiropoulos

Abstract

Accumulation of aggregated α-synuclein into Lewy bodies is thought to contribute to the onset and progression of dopaminergic neuron degeneration in Parkinson's disease (PD) and related disorders. Although protein aggregation is associated with perturbation of proteostasis, how α-synuclein aggregation affects the brain proteome and signaling remains uncertain. In a mouse model of α-synuclein aggregation, 6% of 6215 proteins and 1.6% of 8183 phosphopeptides changed in abundance, indicating conservation of proteostasis and phosphorylation signaling. The proteomic analysis confirmed changes in abundance of proteins that regulate dopamine synthesis and transport, synaptic activity and integrity, and unearthed changes in mRNA binding, processing and protein translation. Phosphorylation signaling changes centered on axonal and synaptic cytoskeletal organization and structural integrity. Proteostatic responses included a significant increase in the levels of Lmp7, a component of the immunoproteasome. Increased Lmp7 levels and activity were also quantified in postmortem human brains with PD and dementia with Lewy bodies. Functionally, the immunoproteasome degrades α-synuclein aggregates and generates potentially antigenic peptides. Exp...Continue Reading

References

Sep 27, 1994·Proceedings of the National Academy of Sciences of the United States of America·M GaczynskaA L Goldberg
Sep 1, 1995·Neurodegeneration : a Journal for Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration·V Jackson-LewisS Przedborski
Aug 28, 1997·Nature·M G SpillantiniM Goedert
May 23, 1998·The Journal of Biological Chemistry·W S DavidsonJ M George
Jun 24, 1998·Proceedings of the National Academy of Sciences of the United States of America·J AraH Ischiropoulos
Sep 19, 2001·The Journal of Biological Chemistry·A IwataN Nukina
Jan 29, 2002·Nature Cell Biology·Hideo FujiwaraTakeshi Iwatsubo
Sep 5, 2002·Annals of Neurology·John E DudaJohn Q Trojanowski
Nov 1, 2003·Science·A B SingletonK Gwinn-Hardy
Feb 3, 2004·Annals of Neurology·Matt FarrerJ William Langston
Feb 12, 2004·Archives of Biochemistry and Biophysics·Cheryl Y Teoh, Kelvin J A Davies
Jun 11, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Barbara PicconiMonica Di Luca
Oct 7, 2004·Proceedings of the National Academy of Sciences of the United States of America·Sreeganga ChandraThomas C Südhof
Jun 10, 2005·Proceedings of the National Academy of Sciences of the United States of America·Sylvia HeinkElke Krüger
Nov 22, 2005·Neurobiology of Aging·Michele MishtoClaudio Franceschi
Feb 16, 2008·Science·William E BalchJeffery W Kelly
Apr 17, 2008·Acta Neuropathologica·Elisa A WaxmanBenoit I Giasson
Mar 20, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Chee Yeun ChungOle Isacson
Mar 21, 2009·Annual Review of Biochemistry·Evan T PowersWilliam E Balch
Jan 15, 2010·The Journal of Biological Chemistry·He-Jin LeeSeung-Jae Lee
Jan 16, 2010·International Journal of Immunopathology and Pharmacology·H WilmsR Lucius
May 21, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Evangelia EmmanouilidouKostas Vekrellis
Jun 11, 2010·Brain : a Journal of Neurology·Pablo Garcia-ReitböckMaria Grazia Spillantini
Jun 18, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·David A ScottSubhojit Roy
Aug 12, 2010·Proceedings of the National Academy of Sciences of the United States of America·John C PriceSina Ghaemmaghami
Sep 8, 2010·The Journal of Cell Biology·Peter M Douglas, Andrew Dillin
Nov 5, 2010·Molecular & Cellular Proteomics : MCP·Dirk M Walther, Matthias Mann
Oct 14, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Darius Ebrahimi-FakhariVivek K Unni
Dec 27, 2011·Nature Immunology·Eleanor Z KincaidKenneth L Rock

❮ Previous
Next ❯

Citations

Jan 12, 2019·Movement Disorders : Official Journal of the Movement Disorder Society·Danielle E MorHarry Ischiropoulos
May 8, 2019·International Journal of Molecular Sciences·Fiona LimanaqiFrancesco Fornai
Oct 2, 2020·Cells·Tuuli-Maria SonninenŠárka Lehtonen
Mar 8, 2020·Journal of Alzheimer's Disease : JAD·Sky DominguezHongxin Dong
Apr 30, 2020·International Journal of Molecular Sciences·Fiona LimanaqiFrancesco Fornai
Jan 9, 2021·Cell Death and Differentiation·Marlene F SchmidtGrant Dewson
Feb 27, 2021·Frontiers in Neuroscience·Gianfranco NataleFrancesco Fornai
Sep 10, 2020·Neuroscience Letters·Congcong SunYiming Liu
Aug 15, 2021·Neurobiology of Disease·Abby L Olsen, Mel B Feany

❮ Previous
Next ❯

Datasets Mentioned

BETA
PXD009647

Methods Mentioned

BETA
reverse phage chromatography
Assay

Software Mentioned

Motif
GeneMANIA
Perseus
GOplot
DAVID Bioinformatics Resources
MaxQuant

Related Concepts

Related Feeds

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Alpha-Synuclein Aggregation

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Related Papers

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
O S LevinO S Zimniakova
Proceedings of the National Academy of Sciences of the United States of America
Qian RenKenji Hashimoto
© 2022 Meta ULC. All rights reserved